You need to do your due diligence on the product's potential market and whether the product offers a point of different, this has always been the limitation of PCK's technology.......why do you think IMU has a $1.5B MC for a biotech start-up
News: PCK Painchek Announces A$1.59M Underwritten Non-Renounceable Pro-Rata Entitlement Offer, page-43
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.80M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.8¢ | 2.6¢ | $42.19K | 1.560M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1486659 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 387949 | 1 |
View Market Depth
| Last trade - 14.58pm 27/01/2025 (20 minute delay) ? |
| PCK (ASX) Chart |